<p>CEO Will Lansing has presided over one of the most extraordinary value creation stories in American corporate history — and simultaneously one of the most aggressive financial engineering campaigns. Under his tenure (CEO since January 2012, over 14 years), FICO's revenue has grown from $620 million to $1.99 billion, operating margins have expanded from 22.6% to 47.0%, EPS has compounded from $1.82 to $26.90, and the stock has risen from roughly $40 to $995 — a 2,400% return before the recent correction from highs above $2,000. By any operational measure, this is an elite management performance. The ROIC expansion from 10.3% to 58.5% documented in Chapter 5 occurred entirely under Lansing's watch, driven by the deliberate monetization of FICO's monopoly position through score repricing, margin discipline, and capital-light operations. These are not accidental outcomes; they reflect a CEO who understood the structural power of his company's monopoly position and systematically harvested it.</p> <p>The governance concern, however, is concentrated in a single dimension: <strong>capital allocation at the margin</strong>. Chapter 7 documented that FICO spent $1.415 billion on buybacks in FY2025 against $770 million in free cash flow, funding the $645 million gap with debt. More troubling, Q1 FY2026 buybacks were executed at an average price of $1,707 per share — 72% above today's $995 price. Over the five-year period FY2021-2025, cumulative buybacks totaled $4.62 billion against $2.78 billion in cumulative FCF, with the $1.84 billion gap funded entirely by debt that now stands at $3.46 billion. This is not the behavior of management that thinks like owners; this is the behavior of management optimizing EPS accretion as a compensation-relevant metric, potentially at the expense of long-term balance sheet strength. The proxy statement reveals that FICO is proposing to amend its certificate of incorporation to allow officer exculpation (Proposal 4 in the DEF 14A), which would shield officers from personal liability for breaches of fiduciary duty — a governance change that ISS typically recommends voting against, and one that raises questions about whether management is preparing legal defenses for aggressive financial decisions.</p> <p>The legal overhang from the Sherman Act Section 2 antitrust litigation represents the most material governance risk. The case survived a motion to dismiss in November 2024, with monopolization claims allowed to proceed through discovery. CEO Lansing's dismissive tone toward lender concerns on the Q1 earnings call — repeatedly characterizing legitimate industry pushback as "misplaced, misguided" — suggests either supreme confidence in FICO's legal position or insufficient humility about the regulatory and litigation risks that aggressive monopoly pricing inevitably attracts. For a company whose entire value creation thesis depends on unconstrained pricing power, the governance posture toward antitrust risk deserves more seriousness than it appears to receive.</p> <p>On insider ownership, the Form 4 data shows recent director purchases in the $247-$392 range during February 2026 — notably, at prices 60-75% below the $995 current price and far below the $1,707 at which management was buying back shares just weeks earlier. Board members David Rey purchased 3,192 shares ($791,041) and Eva Manolis purchased 520 shares ($128,866) at approximately $248 per share. These are meaningful insider purchases that suggest board members view the current depressed price as a genuine buying opportunity — a positive governance signal.</p>